Gone to the dogs? Shire sells vaccine plant to Merck Animal Health
Shire has sold the former Baxalta vaccine facility in Austria to Merck Animal Health for an undisclosed fee.
Archives for August 22, 2017
Oxford Genetics secures investment; expands UK facility and eyes US market
Oxford Genetics will expand its bioproduction services in the UK and target the US market through an office in Boston after receiving a £7.5m ($9.6m) investment.
Pfizer’s ADC ambition bolstered by US Besponsa approval
Pfizer has been granted US approval for its antibody-drug conjugate (ADC) Besponsa, to be manufactured at the firm’s Pearl River, New York facility.